{"SPADE_UN_11848": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11848", "Peptide Name": "SLZP (De novo synthesis)", "Source": "Synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "LRRLLRWLRRLLRR", "Sequence Length": 14, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic form", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-", "Antifungal"], "Target Organism": "[Ref.25069749] Gram-positive bacteria :Staphylococcus aureus (ATCC 25923)(MIC=1.56 μg/ml), Bacillus cereus(MIC=3.15 μg/ml);Gram-negative bacteria :E. coli (ATCC 9637)(MIC=25 μg/ml), Pseudomonas aeruginosa (ATCC BAA-427)(MIC=25 μg/ml), Klebsiella pneumoniae (ATCC 27736)(MIC=3.15 μg/ml);Fungi :Sporothrix schenckii(MIC=3.15 μg/ml), Trichophyton mentagrophytes(MIC=6.25 μg/ml), Aspergillus fumigatus(MIC=6.25 μg/ml), Candida parapsilosis (ATCC 22019)(MIC=6.25 μg/ml)", "Hemolytic Activity": "[Ref.25069749] 15% hemolysis at 10 μg/ml , 25% hemolysis at 20 μg/ml , 30% hemolysis at 30 μg/ml , 40% hemolysis at 40 μg/ml , 50% hemolysis at 50 μg/ml , 55% hemolysis at 60 μg/ml , 70% hemolysis at 70 μg/ml , 80% hemolysis at 80μg/ml against human red blood cells", "Cytotoxicity": "[Ref.25069749] The cell viability of murine fibroblast cells (3T3) is 85.9%, 77.5%, 73.7%, 50.0%, 23.7% and 0% at peptide concentrations of 1.5, 3, 4.5, 6 and 9 μM.", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C89H162N36O15", "Mass": 1976.47, "PI": 12.0, "Net Charge": 7, "Hydrophobicity": -0.69, "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Sporothrix schenckii, Trichophyton mentagrophytes, Aspergillus fumigatus, Candida parapsilosis", "Literature": [{"Title": "Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms", "Pubmed ID": "25069749", "Reference": "Amino Acids. 2014 Nov;46(11)2531-43. doi 10.1007/s00726-014-1802-3.", "Author": "Ahmad A, Azmi S, Srivastava S, Kumar A, Tripathi JK, Mishra NN, Shukla PK, Ghosh JK", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=25069749"}], "Frequent Amino Acids": "RLW", "Absent Amino Acids": "ACDEFGHIKMNOPQSTUVY", "Basic Residues": 7, "Acidic Residues": 0, "Hydrophobic Residues": 7, "Polar Residues": 7, "Positive Residues": 7, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_07062", "Similarity": 1.0, "Sequence": "LRRFSTMPFMFCNINNVCNF"}, {"SPADE_ID": "SPADE_N_11410", "Similarity": 1.0, "Sequence": "LRRG"}, {"SPADE_ID": "SPADE_N_11418", "Similarity": 1.0, "Sequence": "LRR"}]}}}